Analystreport

Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.

Crinetics Pharmaceuticals, Inc.  (CRNX) 
Last crinetics pharmaceuticals, inc. earnings: 3/9 04:10 pm Check Earnings Report